Search Results for: EGFR

Novel Interactant Symbol Name
Associated Pathways
Binding Drugs
Associated Diseases
SOCS6 suppressor of cytokine signaling 6
  • Regulation of KIT signaling
  • Neddylation
  • Negative regulation of FLT3
SUPT6H SPT6 homolog, histone chaperone and transcription elongation factor
  • Formation of RNA Pol II elongation complex
  • RNA Polymerase II Pre-transcription Events
  • RNA Polymerase II Transcription Elongation
ADRM1 adhesion regulating molecule 1
  • UCH proteinases
  • Ub-specific processing proteases
AIP aryl hydrocarbon receptor interacting protein
  • Aryl hydrocarbon receptor signalling
  • Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation
AMH anti-Mullerian hormone
  • Signaling by BMP
  • Transcriptional regulation of testis differentiation
  • 46,XY disorders of sex development (Other), including: Persistent Mullerian duct syndrome; Hypospadias; Cryptorchidism
ATP5F1C ATP synthase F1 subunit gamma
  • Formation of ATP by chemiosmotic coupling
  • Cristae formation
  • Quercetin
  • 1-ACETYL-2-CARBOXYPIPERIDINE
  • AUROVERTIN B
  • Piceatannol
  • N1-(2-AMINO-4-METHYLPENTYL)OCTAHYDRO-PYRROLO[1,2-A] PYRIMIDINE
BLK BLK proto-oncogene, Src family tyrosine kinase
  • RUNX1 regulates transcription of genes involved in BCR signaling
  • Antigen activates B Cell Receptor (BCR) leading to generation of second messengers
  • Fostamatinib
  • Zanubrutinib
  • Maturity onset diabetes of the young (MODY)
BMX BMX non-receptor tyrosine kinase
  • Apoptotic cleavage of cellular proteins
  • Synthesis of PIPs at the plasma membrane
  • Fostamatinib
  • Zanubrutinib
CAV3 caveolin 3
  • Smooth Muscle Contraction
  • Smooth Muscle Contraction
  • Caveolinopathies, including: Limb-girdle muscular dystrophy (LGMD) 1C; Rippling muscle disease (RMD); Idiopathic hyperCKemia; Distal myopathy with decreased caveolin 3; Hypertrophic cardiomyopathy (HCM)
  • Long QT syndrome, including: Romano-Ward syndrome; Jervell and Lange-Nielsen syndrome (JLNS)
  • Limb-girdle muscular dystrophy (LGMD)
CDH5 cadherin 5
  • Adherens junctions interactions
  • VEGFR2 mediated vascular permeability
  • Lenalidomide
  • FX06
CTTN cortactin
  • RHO GTPases activate PAKs
  • Clathrin-mediated endocytosis
DEGS1 delta 4-desaturase, sphingolipid 1
  • Sphingolipid de novo biosynthesis
  • Neutrophil degranulation
DOK2 docking protein 2
  • Tie2 Signaling
  • RET signaling
FANCC FA complementation group C
  • Fanconi Anemia Pathway
  • TP53 Regulates Transcription of DNA Repair Genes
  • Fanconi anemia
FRAT2 FRAT regulator of WNT signaling pathway 2
  • Beta-catenin phosphorylation cascade
  • Disassembly of the destruction complex and recruitment of AXIN to the membrane
FRK fyn related Src family tyrosine kinase
  • Neutrophil degranulation
  • Regulation of PTEN stability and activity
  • Dasatinib
  • Regorafenib
  • Fostamatinib
  • Zanubrutinib
GABARAPL2 GABA type A receptor associated protein like 2
  • Macroautophagy
  • TBC/RABGAPs
GAPDH glyceraldehyde-3-phosphate dehydrogenase
  • Glycolysis
  • Gluconeogenesis
  • NADH
  • Adenosine-5-Diphosphoribose
  • Thionicotinamide-Adenine-Dinucleotide
  • 4-(2-Aminoethyl)Benzenesulfonyl Fluoride
  • Xanthinol
  • Copper
  • Artenimol
GGA1 golgi associated, gamma adaptin ear containing, ARF binding protein 1
  • TBC/RABGAPs
  • Amyloid fiber formation
HPN hepsin
  • MET Receptor Activation
  • Signaling by MST1
  • Bentiromide
  • Benzylsulfonic acid
  • CRA_1144
  • 6-Chloro-2-(2-Hydroxy-Biphenyl-3-Yl)-1h-Indole-5-Carboxamidine

Page 12 out of 21 pages